Semi-Regulated General Products
No |
Generic Name |
Dosage Form |
Strength |
Market |
Penicillins |
1 |
Amoxicillin |
Capsules |
250, 500 mg |
Emerging Market |
2 |
Amoxycillin |
Dispersible Tablet for Suspension |
250, 1000 mg |
Emerging Market |
3 |
Amoxicillin |
PFOS |
125 mg/5ml, 250mg/5ml, 500mg/5ml |
Emerging Market |
4 |
Amoxicillin and Clavulanate Potassium |
PFOS |
156.25mg/5ml, 228.5mg/5ml, 312.5mg/5ml, 457mg/5ml |
Emerging Market |
5 |
Amoxicillin and Clavulanate Potassium |
Tablet |
375, 625, 1000 mg |
Emerging Market |
6 |
Cloxacillin |
Capsules |
500 mg |
Emerging Market |
7 |
Cloxacillin |
PFOS |
125 mg/5ml |
Emerging Market |
8 |
Dicloxacillin |
Capsules |
500 mg |
Emerging Market |
9 |
Flucloxacillin |
Capsules |
500 mg |
Emerging Market |
10 |
Ampicillin + Cloxacillin |
Capsules |
250 mg + 250 mg |
Emerging Market |
11 |
Ampicillin + Cloxacillin |
PFOS |
125 mg + 125 mg / 5ml |
Emerging Market |
Cephalosporins |
12 |
Cefaclor |
PFOS |
50 mg/ml |
Emerging Market |
13 |
Cefaclor |
PFOS |
125 mg/5ml, 187 mg/5ml |
Emerging Market |
14 |
Cefaclor |
Capsules |
500 mg |
Emerging Market |
15 |
Cefaclor |
Dispersible Tablet |
125, 250 mg |
Emerging Market |
16 |
Cefaclor |
Control Release Tablet |
375, 750 mg |
Emerging Market |
17 |
Cefaclor |
Sachet |
125 mg |
Emerging Market |
18 |
Cefalexin |
Capsules |
250, 500 mg |
Emerging Market |
19 |
Cefalexin |
PFOS |
125 mg/5ml, 250 mg/5ml |
Emerging Market |
20 |
Cefixime |
Dispersible Tablet |
100, 200, 400 mg |
Emerging Market |
21 |
Cefixime |
PFOS |
50 mg/5ml, 100 mg/5ml |
Emerging Market |
22 |
Cefpodoxime Proxetil |
PFOS |
50 mg/5ml, 100 mg/5ml |
Emerging Market |
23 |
Cefpodoxime Proxetil |
Tablet |
100, 200 mg |
Emerging Market |
24 |
Cefuroxime Axetil |
PFOS |
125 mg/5ml, 250 mg/5ml |
Emerging Market |
25 |
Cefuroxime Axetil |
Tablet |
250, 500 mg |
Emerging Market |
26 |
Cefdinir |
Capsules |
300 mg |
Emerging Market |
27 |
Cefdinir |
PFOS |
125 mg/5ml, 250 mg/5ml |
Emerging Market |
28 |
Cefadroxil |
Capsule |
500 mg |
Emerging Market |
29 |
Cefadroxil |
PFOS |
250 mg/5ml |
Emerging Market |
30 |
Cefprozil |
PFOS |
125 mg/5ml, 250 mg/5ml |
Emerging Market |
31 |
Cefprozil |
Tablet |
250, 500 mg |
Emerging Market |
NSAID |
32 |
Paracetamol |
Oral Suspension |
125mg / 5ml, 250mg/5ml |
Emerging Market |
33 |
Paracetamol |
Oral Drop |
100mg/ml |
Emerging Market |
34 |
Paracetamol |
Oral Solution |
120mg/5ml, 160mg/5ml |
Emerging Market |
35 |
Paracetamol |
Tablet |
500 mg |
Emerging Market |
36 |
Paracetamol |
Sachet |
100mg |
Emerging Market |
37 |
Aceclofenac |
Tablet |
100 mg |
Emerging Market |
38 |
Aceclofenac + Paracetamol |
Tablet |
100 + 500 mg |
Emerging Market |
39 |
Diclofenac |
Capsule SR |
100 mg |
Emerging Market |
40 |
Mefenamic Acid |
Tablet |
500 mg |
Emerging Market |
41 |
Meloxicam |
Tablet |
7.5, 15 mg |
Emerging Market |
42 |
Celecoxib |
Capsules |
100, 200 mg |
Emerging Market |
43 |
Etoricoxib |
Tablet |
60, 90, 120 mg |
Emerging Market |
44 |
Ibuprofen |
Oral Suspension |
100mg/5ml, 200mg/5ml |
Emerging Market |
45 |
Tramadol |
Oral Drop |
100mg/ml |
Emerging Market |
46 |
Tramadol |
Capsules |
50mg/100mg |
Emerging Market |
47 |
Tramadol + Paracetamol |
Tablet |
37.5 + 325mg |
Emerging Market |
48 |
Naproxen |
IR Tablet |
250, 500 mg |
Emerging Market |
49 |
Naproxen Sodium |
IR Tablet |
220, 275, 550mg |
Emerging Market |
Xanthine Oxidase Inihibitors |
50 |
Allopurinol |
Tablet |
100,300 mg |
Emerging Market |
Cardiovascular |
51 |
Amlodipine Besylate |
Tablet |
5,10 mg |
Emerging Market |
52 |
Lisinopril |
Tablet |
5, 10 mg |
Emerging Market |
53 |
Atorvastatin |
Tablet |
10, 20, 40 mg |
Emerging Market |
54 |
Rosuvastatin |
Tablet |
5, 10, 20 mg |
Emerging Market |
55 |
Losartan Potassium |
Tablet |
25, 50, 100 mg |
Emerging Market |
56 |
Losartan Potassium + Hydrochlorothiazide |
Tablet |
25+12.5 mg, 50+25 mg, 100+25 mg |
Emerging Market |
58 |
Clopidogrel |
Tablets |
75 mg |
Emerging Market |
Macrolide |
58 |
Azithromycin |
PFOS |
200 mg / 5ml |
Emerging Market |
59 |
Azithromycin |
Oral Solution |
200mg/5ml |
Emerging Market |
60 |
Azithromycin |
Tablet / Capsule |
250, 500 mg |
Emerging Market |
Proton-pump inhibitors (PPIs) |
61 |
Esomeprazole |
Tablet |
20, 40 mg |
Emerging Market |
62 |
Omeprazole |
Capsule |
20 mg |
Emerging Market |
Fluoroquinolones Antibiotics |
63 |
Levofloxacin |
Tablet |
250, 500 mg, 750 mg |
Emerging Market |
64 |
Ciprofloxacin |
Tablet |
250, 500 mg |
Emerging Market |
Anti Histaminic |
65 |
Fexofenadine |
Tablet |
120, 180 mg |
Emerging Market |
66 |
Levocetirizine |
Oral Solution |
500 mcg/ml, 1000 mcg/ml |
Emerging Market |
67 |
Desloratadine |
Tablet Mouth Dissolving |
5 mg |
Emerging Market |
68 |
Desloratadine |
Oral Solution |
2.5 mg/5 ml |
Emerging Market |
Antifungal |
69 |
Fluconazole |
Tablet / Capsule |
150 mg |
Emerging Market |
70 |
Fluconazole |
Capsule |
200 mg |
Emerging Market |
Anti Diabetics |
71 |
Gliclazide |
IR and ER Tablet |
30, 60 mg (ER), 80 mg (IR) |
Emerging Market |
72 |
Metformin |
ER Tablet |
500, 750, 1000 mg |
Emerging Market |
73 |
Glibenclamide + Metformin |
Tablet |
5 + 500 mg |
Emerging Market |
74 |
Glimepiride + Metformin |
Tablet |
2 mg (IR) + 500 mg (ER) |
Emerging Market |
Anticonvulsants |
75 |
Pregabalin |
Capsules |
75, 150, 300 mg |
Emerging Market |
76 |
Pregabalin + Methylcobalamin |
Capsules |
75 mg + 750 mcg |
Emerging Market |
77 |
Citicoline Tablet |
Tablet |
500 mg |
Emerging Market |
78 |
Citicoline |
Oral Solution |
500 mg/5 ml |
Emerging Market |
79 |
Levetiracetam |
Oral Solution |
100 mg/ml |
Emerging Market |
Phosphodiesterase (PDE) inhibitors |
80 |
Sildenafil Citrate |
Tablet |
50, 100 mg |
Emerging Market |
81 |
Tadalafil Citrate |
Tablet |
5, 10, 20 mg |
Emerging Market |
Anticold formulations / Respiratery |
82 |
Each 5ml Contains : PCM + Phenylephrine HCL + CPM |
Oral Solution |
125mg+2.5mg+1mg |
Emerging Market |
83 |
PCM + Caffeine + Phenylephrine HCL + CPM |
Tablet |
500mg+30mg+5mg+2mg |
Emerging Market |
84 |
Each Sachet contains : PCM + Noscapine + Caffeine |
Sachet (Day) |
400mg+10mg+33mg |
Emerging Market |
85 |
Each Sachet contains : PCM + CPM +Phenylephrine HCL |
Sachet (Night) |
400mg+10mg+4mg+33mg |
Emerging Market |
86 |
PCM + CPM + Phenylephrine HCL |
Sachet |
650mg+4mg+10mg |
Emerging Market |
87 |
PCM + Caffeine + Phenylephrine HCL + Phenramine Maleate |
Sachet |
750mg+30mg+10mg+20mg |
Emerging Market |
88 |
PCM + Dextromethorphan + CPM + Phenylephrine |
Capsules |
500mg+15mg+2mg+10mg |
Emerging Market |
89 |
Paracetamol + CPM + Caffeine + Noscapine HCL + Sodium Ascorbate |
Sachet (Night) |
400mg+4mg+33mg+10mg+56.3mg |
Emerging Market |
90 |
Paracetamol+Caffeine+ Noscapine HCL and Sodium Ascorbate Powder for Sachet |
Sachet (Day) |
400mg+33mg+10mg+56.3mg |
Emerging Market |
91 |
Bromhexine Syrup |
Oral Solution |
s |
Emerging Market |
92 |
Ambroxol Syrup |
Oral Solution |
30mg/5ml |
Emerging Market |
93 |
Montelukast Oral Suspension |
Oral Suspension |
4mg/5ml |
Emerging Market |
94 |
Levocetrizine |
Oral Solution |
2.5mg/5ml, 5mg/5ml |
Emerging Market |
95 |
Levodropiopizine |
Oral Solution |
30mg/5ml, 60mg/10ml |
Emerging Market |
96 |
Oxalamine Citrate for Infants |
Oral Solution |
28mg/5ml |
Emerging Market |
97 |
Oxalamin (As Phosphate) for Adult |
Oral Solution |
50mg/5ml |
Emerging Market |
98 |
Each 5ml Contains : PCM + Pseudoephedrine + CPM |
Oral Solution |
125mg+30mg+2mg |
Emerging Market |
99 |
Each 5ml contains : Pseudoephedrine + CPM |
Oral Solution |
30mg+2mg |
Emerging Market |
100 |
Each 5ml contains : Dry extract of dried leaves of Hedera Helix L (Ivy) 35mg/5ml |
Oral Solution |
35mg/5ml |
Emerging Market |
General Products
No |
Generic Name |
Dosage Form |
Strength |
Market |
Antidiabetic and Anticoagulant Medications |
1 |
Dapagliflozin |
Tablet |
5, 10 mg |
Regulated Market |
2 |
Dapagliflozin + Metformin* |
XR Tablet |
5 + 500 mg |
Regulated Market |
3 |
Dapagliflozin + Metformin* |
XR Tablet |
10 + 500 mg |
Regulated Market |
4 |
Dapagliflozin + Metformin* |
XR Tablet |
2.5 + 1000 mg |
Regulated Market |
5 |
Dapagliflozin + Metformin* |
XR Tablet |
5 + 1000 mg |
Regulated Market |
6 |
Dapagliflozin + Metformin* |
XR Tablet |
10 + 1000 mg |
Regulated Market |
7 |
Dapagliflozin + Metformin# |
IR Tablet |
5 + 1000 mg |
Regulated Market |
8 |
Dapagliflozin + Metformin# |
IR Tablet |
5 + 850 mg |
Regulated Market |
9 |
Empagliflozin |
Tablet |
10, 25 mg |
Regulated Market |
10 |
Empagliflozin + Metformin* |
XR Tablet |
5 + 1000 mg |
Regulated Market |
11 |
Empagliflozin + Metformin* |
XR Tablet |
10 + 1000 mg |
Regulated Market |
12 |
Empagliflozin + Metformin* |
XR Tablet |
12.5 + 1000 mg |
Regulated Market |
13 |
Empagliflozin + Metformin* |
XR Tablet |
25 + 1000 mg |
Regulated Market |
14 |
Empagliflozin + Metformin |
IR Tablet |
5 + 1000 mg |
Regulated Market |
15 |
Empagliflozin + Metformin |
IR Tablet |
12.5 + 1000 mg |
Regulated Market |
16 |
Empagliflozin + Metformin* |
IR Tablet |
5 + 500 mg |
Regulated Market |
17 |
Empagliflozin + Metformin* |
IR Tablet |
12.5 + 500 mg |
Regulated Market |
18 |
Empagliflozin + Metformin# |
IR Tablet |
12.5 + 850 mg |
Regulated Market |
19 |
Empagliflozin + Metformin# |
IR Tablet |
5 + 850 mg |
Regulated Market |
20 |
Linagliptin |
Tablet |
5 mg |
Regulated Market |
21 |
Sitagliptin |
Tablet |
25, 50, 100 mg |
Regulated Market |
22 |
Sitagliptin + Metformin |
IR Tablet |
50 + 1000 mg |
Regulated Market |
23 |
Sitagliptin + Metformin* |
IR Tablet |
50 + 500 mg |
Regulated Market |
24 |
Sitagliptin + Metformin# |
IR Tablet |
50 + 850 mg |
Regulated Market |
25 |
Sitagliptin + Metformin* |
XR Tablet |
50 + 1000 mg |
Regulated Market |
26 |
Sitagliptin + Metformin* |
XR Tablet |
50 + 500 mg |
Regulated Market |
27 |
Sitagliptin + Metformin* |
XR Tablet |
100 + 1000 mg |
Regulated Market |
28 |
Ticagrelor |
IR Tablet |
60, 90 mg |
Regulated Market |
29 |
Apixaban |
IR Tablet |
2.5, 5 mg |
Regulated Market |
30 |
Rivaroxaban |
IR Tablet |
10, 15, 20 mg |
Regulated Market |
31 |
Imeglimin |
IR Tablet |
500, 1000 mg |
Regulated Market |
Cardiovascular and Lipid-Lowering Medications |
32 |
Ticagrelor |
IR Tablet |
60, 90 mg |
Regulated Market |
33 |
Apixaban |
IR Tablet |
2.5, 5 mg |
Regulated Market |
34 |
Rivaroxaban |
IR Tablet |
10, 15, 20 mg |
Regulated Market |
35 |
Gemfibrozil |
IR Tablet |
300, 600 mg |
Regulated Market |
36 |
Edoxaban |
IR Tablet |
15, 30, 60 mg |
Regulated Market |
37 |
Sacubitril:Valsartan |
IR Tablet |
24/26 mg |
Regulated Market |
38 |
Sacubitril:Valsartan |
IR Tablet |
49/51 mg |
Regulated Market |
39 |
Sacubitril:Valsartan |
IR Tablet |
97/103 mg |
Regulated Market |
CNS (Our New Range) |
40 |
Levodopa + Benserazide |
IR Tablet |
50/100/200 mg + 12.5/25/50 mg |
Regulated Market |
41 |
Levetiracetam |
IR Tablet |
500, 100 mg |
Regulated Market |
42 |
Gabapentin |
Capsule |
100, 300, 400 mg |
Regulated Market |
43 |
Melatonin |
IR Tablet |
1, 3, 5 mg |
Regulated Market |
44 |
Melatonin |
XR Tablet |
2 mg |
Regulated Market |
45 |
Melatonin |
Capsule |
2, 3, 5 mg |
Regulated Market |
Gabapentinoids |
46 |
Mirogabalin |
IR Tablet |
2.5, 5, 10, 15 mg |
Regulated Market |
Anti-Biotics |
47 |
Rifaximin |
IR Tablet |
200, 550 mg |
Regulated Market |
ACL Inhibitors |
48 |
Bempedoic Acid, Bempedoic Acid + Ezetimibe |
IR Tablet |
180 mg, 180/10 mg |
Regulated Market |
Calcitonin Gene-Related Peptide Receptor Antagonists |
49 |
Rimegepant |
Orally Disintegrating Tablet |
75 mg |
Regulated Market |
Non-Anticholinergic |
50 |
Mirabegron |
XR Tablet |
25, 50 mg |
Regulated Market |
51 |
Vibegron |
IR Tablet |
75 mg |
Regulated Market |
Anti-Psychotic |
52 |
Cariprazine |
Capsule |
1.5, 3, 4.5, 6 mg |
Regulated Market |
Potassium-Competitive Acid Blockers (PCABs) |
53 |
Vonoprazan |
IR Tablet |
10, 20 mg |
Regulated Market |
54 |
Tegoprazan |
IR Tablet |
50 mg |
Regulated Market |
Mineralocorticoid Receptor (MR) Antagonists |
55 |
Finerinone |
IR Tablet |
10, 20 mg |
Regulated Market |
Gabapentenoids (Our New Range) |
55 |
Mirogabalin |
IR Tablet |
2.5,5,10,15 mg |
Regulated Market |